002581 未名醫藥
按盤價 
10.800 +0.980 (+9.980%)
10.800 +0.980 (+9.980%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.440 | -14.929 | -0.614 | 11.966 | -8.800 |
| 總資產報酬率 ROA (%) | -1.286 | -12.770 | -0.521 | 10.373 | -6.661 |
| 投入資產回報率 ROIC (%) | -1.412 | -14.132 | -0.566 | 11.071 | -7.056 | 邊際利潤分析 |
| 銷售毛利率 (%) | 80.652 | 80.596 | 78.657 | 78.686 | 80.376 |
| 營業利潤率 (%) | -11.508 | -68.255 | 9.430 | 67.811 | -70.679 |
| 息稅前利潤/營業總收入 (%) | -11.444 | -71.178 | 5.609 | 70.558 | -68.613 |
| 淨利潤/營業總收入 (%) | -11.773 | -74.952 | -0.240 | 69.203 | -71.588 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 107.994 | 57.758 | -1,464.805 | -75.986 | 128.645 |
| 價值變動淨收益/利潤總額(%) | -12.733 | -55.126 | 1,708.919 | 169.396 | -54.324 |
| 營業外收支淨額/利潤總額(%) | -4.021 | 6.352 | -164.616 | 1.980 | 3.025 | 償債能力分析 |
| 流動比率 (X) | 8.607 | 3.718 | 1.423 | 2.199 | 3.704 |
| 速動比率 (X) | 7.692 | 3.079 | 1.203 | 1.950 | 3.361 |
| 資產負債率 (%) | 5.114 | 6.992 | 13.571 | 10.359 | 10.351 |
| 帶息債務/全部投入資本 (%) | 0.501 | 0.566 | 7.092 | 6.220 | 5.618 |
| 股東權益/帶息債務 (%) | 19,578.289 | 17,332.748 | 1,296.269 | 1,490.292 | 1,643.217 |
| 股東權益/負債合計 (%) | 1,760.617 | 1,265.802 | 612.512 | 837.013 | 837.178 |
| 利息保障倍數 (X) | 30.078 | -41.719 | 2.742 | 51.213 | -16.067 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 119.087 | 125.947 | 211.052 | 255.369 | 492.859 |
| 存貨周轉天數 (天) | 362.425 | 356.911 | 340.998 | 283.525 | 455.114 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
